# Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

> **NCT06501989** · PHASE2 · WITHDRAWN · sponsor: **Inova Health Care Services**

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Biweekly 5-FLUOROURACIL (5-FU)
- **DRUG:** Biweekly Modified FOLFOX6
- **DRUG:** Biweekly FOLFIRI
- **DRUG:** mFOLFOXIRI

## Key facts

- **NCT ID:** NCT06501989
- **Lead sponsor:** Inova Health Care Services
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-09-19
- **Primary completion:** 2025-09-19
- **Final completion:** 2025-09-19
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Principal Investigator has left Inova
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06501989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06501989, "Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06501989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*